by Lindsey Shapiro, PhD – ALS News Today –
Answer ALS and Cedars-Sinai have made openly available their amyotrophic lateral sclerosis (ALS) patient-based stem cell and biodata repository to researchers worldwide.
The largest of its kind, the repository contains biological and clinical data from nearly 1,000 ALS patients, as well as specialized nerve cells called induced pluripotent stem cells (iPSCs) derived from the patients that scientists can use as a resource for advancing ALS research and treatment.
Researchers can access the resources via the online, open-source Answer ALS Neuromine Data Portal and the Cedars-Sinai Biomanufacturing Center.
